The MEA2100-Beta-Screen-System is an in vitro recording system optimized for diabetes research with beta cells in intact islets of Langerhans. Non-invasive in vitro MEA technology enables acute long-term recording of up to 40 islets simultaneously. Built-in suctions allows fixation and optimal positioning of the islets on the electrodes. The system consists of a 5-channel headstage with build-in perfusion, featuring a sampling rate of 50 kHz per channel at a 24 bit resolution. The digitized data is transferred from the headstage to a signal collector unit for up to four headstages.
Catalog Number: MCS-MEA2100Beta
Request Quote
Please fill in as much details as possible and we will take care of your request as soon as possible
